Pohl-Boskamp

G. Pohl-Boskamp GmbH＆Co.KG provides research, development, and manufacturing of pharmaceutical products and medical devices. The company offers NYDA for the treatment of head lice; GeloMyrtol forte for treating bronchitis and inflamed sinuses; GeloSitin nasal care for treating and moisturizing dry or damaged nasal mucosa; and Gepan infusion for treating cystitis. It operates in Scandinavia, the UK, the Netherlands, France, and Russia. G. Pohl-Boskamp GmbH＆Co.KG was founded in 1835 and is headquartered in Hohenlockstedt, Germany.